AbolerIS Pharma
Research - Nantes, Pays de la Loire, France
AbolerIS Pharma Employees
AbolerIS Pharma Details
AbolerIS Pharma will develop novel and unique therapeutic approaches to induce immune tolerance and preserves useful immune responses in inflammatory, autoimmune and degenerative diseases.Anti-CD45RC monoclonal antibody to deplete effector T cells and preserve regulatory and memory T cells.IL-34 cytokine to induce tolerogenic macrophages/DCs and regulatory T cells.Founded by a team with a long cutting-edge translational expertise in regulatory T cells and mechanisms of tolerance.
Website:
http://www.aboleris-pharma.com
Employees:
8
HQ:
Location:
Nantes, Pays de la Loire, France
Revenue:
AbolerIS Pharma Technologies
Email Providers
Outlook
Load Balancers
Apache
Fonts
Google Font API
Other
Shutterstock